Clinical Trials Directory

Trials / Completed

CompletedNCT07452289

Arthrocentesis of Temporomandibular Joint Using Ozonated Water Alongside With Platelet Rich Plasma Injection in Management of Anterior Disc Displacement Without Reduction:

Arthrocentesis of Temporomandibular Joint Using Ozonated Water Alongside With Platelet Rich Plasma Injection in Management of Anterior Disc Displacement Without Reduction: (Randomized Controlled Clinical Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
16 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Background: The temporomandibular joint (TMJ) is a highly intricate and complex synovial joint found in the human body. When TMJ dysfunction occurs, it causes pain and difficulties in opening the mouth, significantly impacting the patient's quality of life. Internal derangements, characterized by the gradual displacement of the articular disc, stand out as the most prevalent intra-articular temporomandibular disorders. Temporomandibular joint arthrocentesis, a procedure utilizing different irrigating solutions, is acknowledged as an efficient therapy for managing internal derangements of the TMJ. Recently, ozone therapy and orthobiologics like Platelet rich plasma (PRP) have been attracting increasing attention worldwide due to their promising medical applications and diverse therapeutic benefits in management of joint dysfunctions. Aim of this study: The aim of the study is to compare the effectiveness of temporomandibular joint arthrocentesis using ozonated water combined with platelet-rich plasma (PRP) injection versus ozonated water alone for treating Wilkes stages III and IV of anterior disc displacement in terms of pain score, maximum mouth opening, and range of motion. Additionally, the study aims to compare the impact of both treatments on the concentration of the proinflammatory cytokine interleukin-6 (IL-6) in the joint space.

Conditions

Interventions

TypeNameDescription
OTHEROzonated water and PRP injectionpatients will undergo arthrocentesis using ozonated water alongside PRP injection
OTHEROzonated waterpatients will undergo arthrocentesis using ozonated water alone.

Timeline

Start date
2024-07-02
Primary completion
2025-05-15
Completion
2025-05-15
First posted
2026-03-05
Last updated
2026-03-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07452289. Inclusion in this directory is not an endorsement.